GSA CAPITAL PARTNERS LLP - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 173 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$1,835,000
+671.0%
49,160
+429.1%
0.21%
+428.2%
Q1 2021$238,000
-45.2%
9,291
-52.8%
0.04%
-45.1%
Q4 2020$434,000
-1.1%
19,688
-19.3%
0.07%
-2.7%
Q3 2020$439,000
+133.5%
24,388
+138.5%
0.07%
+55.3%
Q1 2020$188,000
-84.8%
10,225
-81.8%
0.05%
-67.4%
Q4 2019$1,238,00056,1890.14%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders